Want to see STE full AI Analyst Report?
Operating Margin by Segment
Shows operating margin for each segment, measuring how efficiently each business converts sales into profit after operating expenses. Wide differences across segments point to where cost control or pricing improvements could meaningfully boost overall profitability.Steris's Healthcare segment shows steady margin improvement, reaching 25% by the end of 2024, supported by volume, pricing, and productivity gains. The AST segment, despite strong revenue growth, faces margin pressures from energy and labor costs. Life Sciences margins have improved significantly, aided by strategic divestitures. The Dental segment has been phased out, reflecting a strategic shift. Overall, Steris's focus on core segments and operational efficiencies is driving margin expansion, although challenges like tariff costs and legal settlements may impact future cash flow.
Date | Healthcare | AST | Life Sciences | Dental |
|---|---|---|---|---|
Jun 30, 2026 | 25.00 | 48.00 | 42.00 | |
Mar 31, 2026 | 25.00 | 45.00 | 43.00 | |
Dec 31, 2025 | 24.00 | 45.00 | 42.00 | |
Sep 30, 2025 | 25.00 | 45.00 | 41.00 | |
Jun 30, 2025 | 24.00 | 48.00 | 43.00 | |
Mar 31, 2025 | 26.00 | 45.00 | 43.00 | |
Dec 31, 2024 | 25.00 | 45.00 | 43.00 | |
Sep 30, 2024 | 24.00 | 43.00 | 42.00 | |
Jun 30, 2024 | 24.00 | 47.00 | 41.00 | |
Mar 31, 2024 | 24.00 | 46.00 | 40.00 |